Autoimmune Diseases / 2011 / Article / Tab 1

Clinical Study

Matrix Metalloproteinase-3 in Myasthenia Gravis Compared to Other Neurological Disorders and Healthy Controls

Table 1

MMP-3 concentrations (ng/mL) in patients with neurological disorders and healthy controls.

MGMSEpilepsyStrokeHealthy controls

Number of patients12459743390
Mean MMP-3 concentration25.5 (±27.4)16.6 (±23.9)19.4 (±16.4)11.7 (±8.1)23.4 (±12.3)
Number of MMP-3-positives19 (15.3%)2 (3.4%)5 (6.7%)04 (4.4%)
Mean MMP-3 concentration of MMP-3-positives79.9 (±27.9)116.5 (±89.8)67.0 (±21.2)054.0 (±3.6)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.